Skip to main content

BARCLAYS PLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in AKBA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$197,646
-$1,289,200 QoQ
Shares Held
142,192
-84.6% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Derivatives in AKBA

reported options exposure · as of Jun 30, 2020
CallValue
$16,296
CallShares
1,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $513,098,829 across 52 Drug Manufacturers - Specialty & Generic names. AKBA ranks #32 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AKBA

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $197,646 142,192
2025-12-31 $1,486,846 923,507
2025-09-30 $3,222,036 1,180,233
2025-06-30 $3,583,623 984,512
2025-03-31 $591,619 308,135
2024-12-31 $713,440 375,495
2024-09-30 $360,472 273,085
2024-06-30 $74,055 72,603
2024-03-31 $384,300 210,000
2022-03-31 $60,416 84,146
2021-12-31 $643,580 284,770
2021-09-30 $542,468 188,357
2021-06-30 $641,555 169,276
2021-03-31 $802,982 237,218
2020-12-31 $458,617 163,792
2020-09-30 $463,077 184,493
2020-06-30 $1,834,032 135,054
2020-06-30 $16,296 1,200
2020-03-31 $78,832 10,400
2020-03-31 $1,013,877 133,757
2020-03-31 $9,096 1,200